semaglutide injection portland just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Semaglutide for Weight Loss in

In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking GLP-1 medications were less than half as likely to die within five years compared to those who werent on the drugs (15.5% versus 37.1%)

Always consult with a licensed clinician to ensure your treatment plan is tailored to your unique medical history, maximizing benefits while minimizing these potential complications

Cons: May cause jitteriness or affect blood pressure in sensitive individuals (rare)

As isolated as an air-stable solid and available commercially, cobalt in vitamin B 12 (cyanocobalamin and other vitamers) is present in its +3 oxidation state

Postpartum and Breastfeeding Considerations GLP-1 receptor agonists are not recommended while breastfeeding , as their effects on milk production and the infant are unknown

For a 180-pound (82 kg) person, that translates to roughly 98 to 123 grams of protein daily